创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

名中医林上助教授治疗气虚络瘀型慢性萎缩性胃炎用药规律及方剂优化分析

Professor Lin Shangzhu, a Renowned Traditional Chinese Medicine Practitioner, Analyzed the Herb Medication Rules and Formula Optimization for Treating Chronic Atrophic Gastritis of Qi Deficiency and Collateral Stasis Pattern

  • 摘要: 目的 采用回顾性研究与数据挖掘技术相结合的方法,系统分析名中医林上助教授治疗气虚络瘀型慢性萎缩性胃炎(chronicatrophic gastritis,CAG)的用药规律,并基于分析结果优化方剂。方法 通过门诊病历系统筛选收集2022年11月21日至2024年11月20日林上助教授接诊的800例气虚络瘀型CAG患者处方,应用Excel建立中药数据库并录入核对数据,导入中医传承计算平台V 3.0分析用药规律。结果 林上助教授治疗气虚络瘀型CAG主要归脾经(42.37%)、胃经(31.82%)、肝经(25.91%),脾经以补虚药和理气药为主,胃经以活血化瘀药和清热药为主。药性分布:温性(43.21%)、平性(28.50%)、微寒性(18.92%),寒性仅占9.37%。药味分布:甘味(36.72%,如甘草、白术)、辛味(29.53%,如当归、吴茱萸)、苦味(23.81%,如黄芩、黄连)等,符合“甘温健脾、辛通络瘀”配伍思想。800张处方涉及187味中药,累计使用频数达16 798次;其中,使用频次在250次以上的中药有20味,最常使用的前5味药依次为麸炒白术(712次)、黄芪(687次)、当归(654次)、北柴胡(623次)和甘草(598次)。补虚药占比25.00%居首,活血化瘀+理气药合计占比40.00%。运用Apriori算法最终筛选“麸炒白术-黄芪”“当归-丹参”“党参-麸炒白术”“陈皮-黄芪”等共10个有效药物配伍组合。使用平台提供的聚类分析模块进行聚类分析,获得5个新方组合。结论 林上助教授治疗气虚络瘀型CAG以“健脾益气-活血通络”为核心,通过动态调方与药对配伍,融合传统气血理论与现代药理机制,科学诠释“脾虚致瘀、气络同治”的学术思想,为临床优化精准治疗提供依据。

     

    Abstract: Objective To systematically analyze the medication pattern of Professor Lin Shangzhu, a renowned traditional Chinese medicine practitioner, in treating chronic atrophic gastritis (CAG) with Qi deficiency and collateral stasis pattern, using a combination of retrospective research and data mining techniques, and to optimize prescriptions based on the findings. Methods A total of 800 prescriptions for CAG patients with Qi deficiency and collateral stasis pattern treated by Professor Lin Shangzhu from November 21, 2022, to November 20, 2024, were collected through the outpatient medical record system. A traditional Chinese medicine database was established using Excel, and data entry and verification were performed. The data was imported into the Traditional Chinese Medicine Inheritance Calculation Platform V3.0 to analyze the medication patterns. Results The prescriptions primarily targeted the Spleen Meridian (42.37%), Stomach Meridian (31.82%), and Liver Meridian (25.91%). Herbs targeting the Spleen Meridian were mainly tonics and Qi-regulating agents, while those for the Stomach Meridian were primarily blood-activating and stasis-resolving herbs and heat-clearing herbs. Property distribution was as follows: warm (43.21%), neutral (28.50%), slightly cold (18.92%), with cold properties accounting for only 9.37%. Flavor distribution included sweet flavor (36.72%, such as Glycyrrhizae Radix Et Rhizoma and Atractylodis Macrocephalae Rhizoma), pungent flavor (29.53%, such as Angelicae Sinensis Radix and Euodiae Fructus), and bitter flavor (23.81%, such as Scutellariae Radix and Coptidis Rhizoma), which was consistent with the compatibility principle of "using sweet and warm to strengthen the spleen, and pungent to unblock collateral stasis." The 800 prescriptions involving 187 traditional Chinese medicines, with a cumulative usage frequency of 16 798 times; Among them, there are 20 herbs were used over 250 times, with the top five being: stir fried bran Atractylodis Macrocephalae Rhizoma(712 times), Astragali Radix(687 times), Angelicae Sinensis Radix(654 times), Bupleurum Chinense (623 times), and Glycyrrhizae Radix Et Rhizoma (598 times). The proportion of tonifying deficiency drugs is the highest at 25.00%, and the total proportion of promoting blood circulation, removing blood stasis, and regulating Qi drugs is 40.00%. The Apriori algorithm identified 10 effective herb-pair combinations, including "stir fried bran Atractylodis Macrocephalae Rhizoma-Astragali Radix", "Angelicae Sinensis Radix-Salviae Miltiorrhizae Radix Et Rhizoma", "Codonopsis Radix-stir fried bran Atractylodis Macrocephalae Rhizoma", and "Citri Reticulatae Pericarpium-Astragali Radix". Cluster analysis yielded 5 new prescription combinations. Conclusion Professor Lin Shangzhu's treatment of CAG with Qi deficiency and collateral stasis pattern is centered on "strengthening the spleen and replenishing, activating blood and unblocking collaterals". Through dynamic prescription adjustment and herb-pair compatibility, it integrates traditional Qi and blood theory with modern pharmacological mechanisms, scientifically interpreting the academic thought of "spleen deficiency leading to stasis, simultaneous treatment of Qi and collaterals", thereby providing a basis for optimizing precise treatment in clinical practice.

     

/

返回文章
返回